WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA Analysis on Cholesterol Lowering Medications

Details
Research
01 October 2008
U.S. Food and Drug AdministrationA U.S. Food and Drug Administration's analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as "Lou Gehrig's Disease." The analysis was reported on Monday, Sept. 29, 2008 in Pharmacoepidemiology and Drug Safety.
Read more ...

Life Competence - the first global picture on the EU-funded health research

Details
Research
30 September 2008
It is now possible to have a global picture of which research organisations and which research areas were funded by the European Commission during the 2001-2006 years (6th European Research Framework Programme). The data has been generated from an online webbased database of competences, supported through an EU specific support action.
Read more ...

European Consumers' Tools to Retrieve Health Information Online

Details
Research
26 September 2008
Manhattan ResearchSearch engines and Wikipedia play a major role in how European consumers retrieve health information online, reports leading global pharmaceutical and healthcare research firm Manhattan Research from its Cybercitizen® Health Europe v8.0 strategic research and advisory service.
Read more ...

A New Computer-Modelling Tool to Improve Psoriasis Management and Treatment Outcomes

Details
Research
23 September 2008
At the 17th EADV Conference in Paris, LEO Pharma has unveiled a new weapon in its long-running campaign to improve psoriasis management and treatment outcomes. However, the weapon is not a new drug but a ground-breaking computer-modelling tool, designed to help those involved in the assessment, planning and provision of psoriasis treatment in primary care to balance optimum outcomes with the growing need for cost control.
Read more ...

Genzyme Marks Grand Opening of New Science Center

Details
Research
23 September 2008
Genzyme Corp.Genzyme Corp. (Nasdaq:GENZ) has marked the grand opening of its new Science Center in Framingham, Mass. The facility serves as a central site for early stage research, where scientists are utilizing the most advanced technologies available to discover novel new treatments for devastating diseases such as Parkinson's, cancer, and heart disease.
Read more ...

A project coordinated by VTT turns plant cells into medical factories

Details
Research
20 September 2008
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
Read more ...

New EudraLex CD v 18 CD with the Pharmaceutical Legislation now available for download

Details
Research
19 September 2008
European UnionNow, you can create your own CD with the whole European Union Pharmaceutical Legislation (Human and Veterinary) and an integrated search engine. The CD content is similar to the EudraLex web site, but it can be used off-line with the search engine. All the documents are in .pdf format and without protection.
Read more ...

More Pharma News ...

  1. Top Pharmaceutical Websites Visited by European Consumers Revealed
  2. FDA to Post Quarterly Report of Potential Safety Issues
  3. Nature inspires new highly specific drugs and organic products
  4. Study overturns century-old rule of pharmacology
  5. Manhattan Research's ePharma Physician® study ranks the top online journals by physician visitation
  6. Abcam and Transinsight Collaborate in the Area of Semantic Search Technologies
  7. Physicians Expect to Shift More Time to Online Professional Resources in the Coming Years
  • Start
  • Prev
  • 282
  • 283
  • 284
  • 285
  • 286
  • 287
  • 288
  • 289
  • 290
  • 291
  • Next
  • End

Business & Industry

  • Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe

Research & Development

  • New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
  • Research identifies, exploits vulnerability in certain high-risk cancers
  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Research

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.